Immunoprecise Antibodies Ltd
NASDAQ:HYFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
|
US |
|
Rosseti Sibir' PAO
MOEX:MRKS
|
RU |
|
Corsa Coal Corp
XTSX:CSO
|
US |
|
A
|
Alpha Professional Holdings Ltd
HKEX:948
|
HK |
|
L
|
Lendingtree Inc
LSE:0JTZ
|
US |
|
O
|
Outin Futures Co Ltd
KOSDAQ:227610
|
KR |
|
Noel Gifts International Ltd
SGX:543
|
SG |
|
C
|
Cobalt Blue Holdings Ltd
OTC:CBBHF
|
AU |
|
VIB Vermoegen AG
LSE:0AC3
|
DE |
|
LeTech Corp
TSE:3497
|
JP |
|
Colefax Group PLC
LSE:CFX
|
UK |
|
Haitian International Holdings Ltd
HKEX:1882
|
CN |
Wall Street
Price Targets
HYFT Price Targets Summary
Immunoprecise Antibodies Ltd
According to Wall Street analysts, the average 1-year price target for
HYFT
is 3.06 USD
with a low forecast of 3.03 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HYFT's stock price target?
Price Target
3.06
USD
According to Wall Street analysts, the average 1-year price target for
HYFT
is 3.06 USD
with a low forecast of 3.03 USD and a high forecast of 3.15 USD.
What is Immunoprecise Antibodies Ltd's Revenue forecast?
Projected CAGR
12%
The
compound annual growth rate
of Immunoprecise Antibodies Ltd's revenue for the next 4 years is
12%.
